In a public notice, the DCI said he must comply with the request to surrender himself to the police for questioning. In a video message, Aroko said he has nothing to fear regarding the ongoing ...

The abstract entitled “A rapid and scalable thymus organoid development method for generating functional T cells” presents progress on the development of a transplantable and scalable ...

The abstract entitled “A rapid and scalable thymus organoid development method for generating functional T cells” presents progress on the development of a transplantable and scalable artificial ...

HOUSTON, April 29, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 240+ patents issued and pending with a focus on ...

AbCellera (Nasdaq: ABCL) today announced new data on its PSMA x CD3 T-cell engagers (TCEs), presented as a poster at the American Association for Cancer Research Ⓡ (AACR) 116th Annual Meeting at ...

The team's study results, published today in the journal Immunity, outline their discovery of a specific type of regulatory T cell that can home back into the thymus and repair the organ when it's ...

Scientists at Xi’an Jiaotong University have fabricated an inverted perovskite solar cell that utilizes a self-assembled bilayer (SAB) as a hole-selective molecular contact. Inverted perovskite ...

The thymus sits in front of the heart and is where T cells mature; its age-related decline is associated with cancer, infections and autoimmune conditions, according to a Dec. 4 release about the ...

AbCellera (ABCL) announced new data on its T-cell engager, or TCE, platform, to be presented as a poster at the Society for Immunotherapy of Cancer, or SITC, 39th Annual Meeting. AbCellera’s ...

The company is developing therapies that center around the thymus, an organ in the chest that creates white blood cells, or “the master regulator of immune tolerance,” according to the biotech.

The US Department of Energy’s National Renewable Energy Laboratory (NREL) has identified a low-cost way to produce high-efficiency III-V solar cells with dynamic hydride vapor phase epitaxy (D ...